CASP3 and breast carcinoma: In contrast, the means of relative caspase 3 activities showed 1.22- and 1.33-fold in EC-CFUs from 8 breast cancer patients treated with 1 and 10 pg/ml of TNF-α in comparison with those treated with vehicle, respectively (Fig. 5B).